Journal Watch

  • PKD liver and kidney size may limit PD

    In Japan, oversized polycystic kidneys may be treated with transcatheter arterial embolization (TAE) to cut off their blood supply and shrink them. Among two small groups of people with PKD, even those with reduced kidney volume still tended to develop hernias.

    Read the abstract » | (added 2015-06-10)

    Tags:

  • Progress toward reengineering catheters to reduce infection

    Can we eliminate exit site infections by redesigning catheters? Bioengineers are working on a way to create a biological seal that would keep germs out. A new device being tested uses a removable protective membrane that slowly grows out of the body, leaving a dry groove that reduces infections—at least in goats.

    Read the abstract » | (added 2015-06-10)

    Tags:

  • Dosage of Tamiflu® for people on PD

    A new study finds that a single, 75mg dose of oseltamivir may be enough for people on PD who don’t have residual kidney function. The more residual function people had, the more efficiently the drug was removed—so more was needed for an optimal response.

    Read the abstract » | (added 2015-05-09)

    Tags:

  • Ultrasound can measure peritoneal wall thickness in children

    Fibrosis of the peritoneum can cause PD failure. But, peritoneal wall thickness can be measured with a painless ultrasound. The results can assess whether the peritoneum is changing over time.

    Read the abstract » | (added 2015-05-09)

    Tags:

  • New index more accurate than Kt/V for PD “adequacy”

    It’s no secret that we at Home Dialysis Central are not fans of Kt/V for HD (or the concept of “adequacy”). A new European study suggests that Kt/V is not useful for PD, either (because it does not account for protein intake), and has tested a substitute index that works better.

    Read the abstract » | (added 2015-05-09)

    Tags: Home dialysis

  • Glucose challenge test (GCT) detects glucose metabolism disorders in PD

    When glucose-based PD fluid is used, it can be a challenge to see if there are blood sugar issues. In 20 people on PD who did not have a history of diabetes, an initial GCT detected impaired glucose tolerance in eleven and diabetes mellitus in four. About 2 years later, twelve patients had glucose metabolism disorders—but none had diabetes.

    Read the abstract » | (added 2015-05-09)

    Tags:

  • Home hemodialysis needs you! Special Kidney International supplement.

    A special supplement of Kidney International focuses on how to implement home hemodialysis, from policies and procedures to equipment, recruitment, safety, prescription, staffing, and more—from global experts. Don't miss it!

    Read the abstract » | (added 2015-05-09)

    Tags: Home dialysis

  • Education can change negative nurse attitudes toward home dialysis

    In-center HD nurses tend to prefer…in-center HD. But, their negative attitudes toward home treatments can be modified, a new study shows. In Canada, a 3-hour educational session with CE credits on the benefits of home treatments, myths about patient eligibility, costs, and a testimonial video did the trick.

    Read the abstract » | (added 2015-05-09)

    Tags:

  • Gene therapy via nanoparticles reduces peritoneal fibrosis in mice

    Gene therapies may reduce peritoneal fibrosis—a leading cause of PD failure. Delivering transforming growth factor using nanoparticles worked in a mouse study.

    Read the abstract » | (added 2015-05-09)

    Tags:

  • Daily HD – fewer hospital days and less dropout than PD

    Compared to PD patients in the USRDS, 1,116 people who did daily home HD had significantly fewer hospital days (5.2 vs. 9.2) and were significantly less likely to switch back to standard in-center treatment (15% vs. 44%). Hospital rates for daily home HD were about the same as those for standard in-center HD in this study.

    Read the abstract » | (added 2015-04-10)

    Tags: